A drug being developed in Aberdeen could transform the lives of millions of Alzheimer’s sufferers.
LMTX has the potential to offer dementia patients “15 years” of extra lucidity and final trials on it are being carried out.
The drug could be on the market within two years.
Magnetic resonance imaging technology pioneered in the north-east helped prove its effectiveness on the human brain. And Aberdeen University’s maths department is helping to handle the huge volumes of data from worldwide tests.
Professor Claude Wischik who is spearheading development of LMTX, said: “If all goes well, 2017 could be when we see this drug in the pharmacies and on the street.”
Aberdeen scientists developing Alzheimer’s drug that could transform the lives of sufferers
